Related references
Note: Only part of the references are listed.The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections A Randomized Trial
Ratko Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Interferon gene expression in sputum cells correlates with the Asthma Index Score during virus-induced exacerbations
E. A. Schwantes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
The co-pathogenesis of influenza viruses with bacteria in the lung
Jonathan A. McCullers
NATURE REVIEWS MICROBIOLOGY (2014)
Rhinovirus-induced interferon production is not deficient in well controlled asthma
Annemarie Sykes et al.
THORAX (2014)
Outgrowth of the Bacterial Airway Microbiome after Rhinovirus Exacerbation of Chronic Obstructive Pulmonary Disease
Philip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma A Case-Control Study
Tricia McKeever et al.
CHEST (2013)
Impaired innate interferon induction in severe therapy resistant atopic asthmatic children
M. R. Edwards et al.
MUCOSAL IMMUNOLOGY (2013)
TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma
Annemarie Sykes et al.
PLOS ONE (2013)
Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study
Patrick White et al.
PLOS ONE (2013)
Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses
Yury A. Bochkov et al.
RESPIRATORY RESEARCH (2013)
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Samy Suissa et al.
THORAX (2013)
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
David Price et al.
PRIMARY CARE RESPIRATORY JOURNAL (2013)
A Mechanistic Role for Type III IFN-λ1 in Asthma Exacerbations Mediated by Human Rhinoviruses
E. Kathryn Miller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Viruses exacerbating chronic pulmonary disease: the role of immune modulation
Aran Singanayagam et al.
BMC MEDICINE (2012)
Risks of Pneumonia in Patients with Asthma Taking Inhaled Corticosteroids
Paul M. O'Byrne et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation
Patrick Mallia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Viruses and asthma
Daniel E. Dulek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
Effect of different asthma treatments on risk of cold-related exacerbations
H. K. Reddel et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro
Janet M. Davies et al.
PLOS ONE (2011)
Interferon-lambda and therapy for chronic hepatitis C virus infection
Raymond P. Donnelly et al.
TRENDS IN IMMUNOLOGY (2011)
Responses of Mouse Airway Epithelial Cells and Alveolar Macrophages to Virulent and Avirulent Strains of Influenza A Virus
Michelle D. Tate et al.
VIRAL IMMUNOLOGY (2011)
Long-term respiratory follow-up of H1N1 infection
Paul Zarogoulidis et al.
VIROLOGY JOURNAL (2011)
Induction and function of type I and III interferon in response to viral infection
David E. Levy et al.
CURRENT OPINION IN VIROLOGY (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Critical Role of Airway Macrophages in Modulating Disease Severity during Influenza Virus Infection of Mice
Michelle D. Tate et al.
JOURNAL OF VIROLOGY (2010)
Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma
Y. A. Bochkov et al.
MUCOSAL IMMUNOLOGY (2010)
Transforming Growth Factor-beta Enhances Rhinovirus Infection by Diminishing Early Innate Responses
Belinda J. Thomas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus
C. L. Skevaki et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
K. Witte et al.
GENES AND IMMUNITY (2009)
Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-λ1) in Response to Influenza A Infection
Jieru Wang et al.
JOURNAL OF IMMUNOLOGY (2009)
Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children.
Francine M. Ducharme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Corticosteroids and β2 Agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements
Michael R. Edwards et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of deficient type III interferon-λ production in asthma exacerbations
Marco Contoli et al.
NATURE MEDICINE (2006)
Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice
Rajeswari Singam et al.
VIROLOGY JOURNAL (2006)
Combination therapy - Synergistic suppression of virus-induced chemokines in airway epithelial cells
MR Edwards et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
PAB Wark et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice
HW Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Interleukin-1β and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects.
J de Kluijver et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Share Paper
